C A Morton

Summary

Country: UK

Publications

  1. ncbi Methyl aminolevulinate: actinic keratoses and Bowen's disease
    Colin A Morton
    Forth Valley Dermatology Centre, Stirling Royal Infirmary, Stirling FK8 2AU, United Kingdom
    Dermatol Clin 25:81-7. 2007
  2. ncbi An open study to determine the efficacy of blue light in the treatment of mild to moderate acne
    C A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk, UK
    J Dermatolog Treat 16:219-23. 2005
  3. ncbi Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma
    C A Morton
    University Department of Dermatology, Western Infirmary, University of Glasgow, Scotland
    Arch Dermatol 137:319-24. 2001
  4. ncbi Realizing the cosmetic potential of topical photodynamic therapy
    C A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk, UK
    J Cosmet Dermatol 1:66-71. 2002
  5. ncbi Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group
    Colin A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk FK1 5QE, U K
    Br J Dermatol 146:552-67. 2002
  6. ncbi The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
    C A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk, UK
    J Dermatolog Treat 13:S25-9. 2002
  7. ncbi Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy
    C A Morton
    University Department of Dermatology, Western Infirmary, Glasgow G11 6NT, UK
    Br J Dermatol 143:767-72. 2000
  8. ncbi Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease
    A Salim
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk FK1 5QE, UK
    Br J Dermatol 148:539-43. 2003
  9. ncbi Guidelines for topical photodynamic therapy: update
    C A Morton
    Department of Dermatology, Stirling Royal Infirmary, Stirling FK2 8AU, UK
    Br J Dermatol 159:1245-66. 2008
  10. ncbi Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma
    J A Leman
    University Department of Dermatology, Western Infirmary, Glasgow, UK
    Clin Exp Dermatol 27:516-8. 2002

Detail Information

Publications21

  1. ncbi Methyl aminolevulinate: actinic keratoses and Bowen's disease
    Colin A Morton
    Forth Valley Dermatology Centre, Stirling Royal Infirmary, Stirling FK8 2AU, United Kingdom
    Dermatol Clin 25:81-7. 2007
    ..Patients with large or multiple lesions of Bowen's disease or those in whom standard therapy, including surgery, is relatively contraindicated may particularly benefit from PDT...
  2. ncbi An open study to determine the efficacy of blue light in the treatment of mild to moderate acne
    C A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk, UK
    J Dermatolog Treat 16:219-23. 2005
    ..The need for alternative therapies remains important. Phototherapy has previously been shown to be effective in acne, with renewed interest as both endogenous and exogenous photodynamic therapies are demonstrated for this condition...
  3. ncbi Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma
    C A Morton
    University Department of Dermatology, Western Infirmary, University of Glasgow, Scotland
    Arch Dermatol 137:319-24. 2001
    ..Patients with large and/or multiple lesions of Bowen disease or BCC can represent a considerable therapeutic challenge. We suggest that delta-ALA PDT may be of particular benefit in such patients...
  4. ncbi Realizing the cosmetic potential of topical photodynamic therapy
    C A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk, UK
    J Cosmet Dermatol 1:66-71. 2002
    ..This review assesses the current data and proposes potential future applications for topical PDT including the treatment of photo-damaged skin...
  5. ncbi Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group
    Colin A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk FK1 5QE, U K
    Br J Dermatol 146:552-67. 2002
    ..A recent British Photodermatology Group workshop considered published evidence on topical PDT in order to establish guidelines to promote the efficacy and safety of this increasingly practised treatment modality...
  6. ncbi The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
    C A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk, UK
    J Dermatolog Treat 13:S25-9. 2002
    ....
  7. ncbi Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy
    C A Morton
    University Department of Dermatology, Western Infirmary, Glasgow G11 6NT, UK
    Br J Dermatol 143:767-72. 2000
    ..A variety of protocols exist for the treatment of Bowen's disease by photodynamic therapy (PDT) using topical 5-aminolaevulinic acid (5-ALA)...
  8. ncbi Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease
    A Salim
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk FK1 5QE, UK
    Br J Dermatol 148:539-43. 2003
    ..CONCLUSIONS: Topical ALA-PDT is more effective than topical 5-FU in the treatment of BD, with fewer adverse events. ALA-PDT should be considered one of the first-line therapeutic options for BD...
  9. ncbi Guidelines for topical photodynamic therapy: update
    C A Morton
    Department of Dermatology, Stirling Royal Infirmary, Stirling FK2 8AU, UK
    Br J Dermatol 159:1245-66. 2008
    ..Management of treatment-related pain/discomfort is a challenge in a minority of patients, and the modality is otherwise well tolerated. Long-term studies provide reassurance over the safety of repeated use of PDT...
  10. ncbi Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma
    J A Leman
    University Department of Dermatology, Western Infirmary, Glasgow, UK
    Clin Exp Dermatol 27:516-8. 2002
    ..Treatment was repeated on four occasions with clinical and histological clearance. ALA-PDT may be a useful addition to the therapeutic options for CTCL. Further studies are required to define optimal treatment protocols...
  11. ncbi Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls
    C A Morton
    Falkirk Royal Infirmary, UK
    J Dermatolog Treat 14:23-6. 2003
    ..Topical PDT using Metvix MAL offers a practical non-invasive therapy option with the potential for high efficacy and good cosmesis...
  12. ncbi Treatment of multiple scalp basal cell carcinomas by photodynamic therapy
    C A Morton
    Department of Dermatology, Western Infirmary, Glasgow, Scotland
    Clin Exp Dermatol 26:33-6. 2001
    ..PDT is a tissue-sparing modality with low morbidity and good cosmesis, leading us to propose 5-aminolaevulinic acid-PDT for multiple superficial basal cell carcinomas of the scalp...
  13. ncbi Photodynamic therapy: applications in dermatology
    J A Leman
    University Department of Dermatology, Western Infirmary Glasgow, G11 6NT, UK
    Expert Opin Biol Ther 2:45-53. 2002
    ..The role of PDT in inflammatory dermatoses remains to be established. The currently available literature is reviewed...
  14. ncbi Topical photodynamic therapy in dermatology
    C A Morton
    Dept. of Dermatology, Royal Infirmary, Falkirk, Scotland
    S Afr Med J 91:634-7. 2001
    ..The development of powerful filtered non-laser sources, along with the topical application of photosensitizer, makes ALA-PDT a more easily accessible therapy...
  15. ncbi Community photo-triage for skin cancer referrals: an aid to service delivery
    C A Morton
    NHS Forth Valley Department of Dermatology, Stirling Royal Infirmary, Stirling, UK
    Clin Exp Dermatol 36:248-54. 2011
    ..We wished to investigate the potential for extending the capacity of the specialist service by using community-based photo-triage for suspected skin cancers...
  16. ncbi Methyl aminolaevulinate photodynamic therapy for Bowen's disease: a practical option?
    Colin A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk, Scotland, UK
    Australas J Dermatol 46:S21-2; discussion S23-5. 2005
  17. ncbi Photodynamic therapy for non-melanoma skin cancer
    Rolf Markus Szeimies
    Klinik und Poliklinik fur Dermatologie, Klinikum der Universitat Regensburg, Germany
    Acta Derm Venereol 85:483-90. 2005
    ..For actinic keratosis and basal cell carcinoma, methyl aminolevulinate-photodynamic therapy is already approved in Europe, Australia and New Zealand, and is now also approved for actinic keratosis in the US...
  18. ncbi Topical photodynamic therapy for Bowen's disease
    Colin A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk, Scotland, UK
    Australas J Dermatol 46:S11; discussion S23-5. 2005
  19. ncbi Non-surgical treatment of skin cancer
    Colin A Morton
    Department of Dermatology, Falkirk Royal Infirmary, Falkirk, Scotland, UK
    Australas J Dermatol 46:S5-7; discussion S23-5. 2005
  20. ncbi Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005
    Lasse R Braathen
    Dermatological University Clinic, Bern, Switzerland
    J Am Acad Dermatol 56:125-43. 2007
    ..PDT may also be a means of preventing certain nonmelanoma skin cancers in immunosuppressed patients...
  21. ncbi Photodynamic therapy for nonmelanoma skin cancer--and more?
    Colin A Morton
    Arch Dermatol 140:116-20. 2004